AGXT and amyotrophic lateral sclerosis: ALS-linked mutations in SPTLC1 cause altered substrate specificity and/or unrestrained activity of SPT (a key enzyme in ceramide synthesis), leading to accumulation of 1-deoxysphingolipids [142] or ceramides [17].